| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |